VC
CYTK icon

Veracity Capital’s Cytokinetics CYTK Stock Holding History

Veracity Capital’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$489K Buy
7,420
+1
+0% +$76 0.13% 132
2026
Q2 		$632K Buy
7,419
+5
+0.1% +$359 0.17% 116
2026
Q1 		$489K Hold
7,414
– – 0.17% 119
2025
Q4 		$471K Hold
7,414
– – 0.14% 149
2025
Q3 		$407K Hold
7,414
– – 0.13% 163
2025
Q2 		$245K Hold
7,414
– – 0.08% 207
2025
Q1 		$298K Hold
7,414
– – 0.12% 172
2024
Q4 		$349K Hold
7,414
– – 0.13% 158
2024
Q3 		$391K Hold
7,414
– – 0.15% 142
2024
Q2 		$402K Sell
7,414
-14
-0.2% -$845 0.17% 126
2024
Q1 		$521K Sell
7,428
-50
-0.7% -$3.87K 0.2% 114
2023
Q4 		$624K Buy
7,478
+44
+0.6% +$1.59K 0.25% 88
2023
Q3 		$219K Sell
7,434
-72
-1% -$2.4K 0.1% 178
2023
Q2 		$245K Buy
7,506
+32
+0.4% +$1.18K 0.1% 188
2023
Q1 		$263K Sell
7,474
-34
-0.5% -$1.39K 0.12% 168
2022
Q4 		$344K Buy
7,508
+7
+0.1% +$301 0.16% 131
2022
Q3 		$363K Sell
7,501
-820
-10% -$39.5K 0.2% 112
2022
Q2 		$327K Hold
8,321
– – 0.17% 130
2022
Q1 		$306K Hold
8,321
– – 0.13% 171
2021
Q4 		$379K Hold
8,321
– – 0.15% 148
2021
Q3 		$297K Buy
+8,321
New +$245K 0.13% 178
2021
Q2 		– Sell
-9,715
Closed -$226K – 266
2021
Q1 		$226K Buy
+9,715
New +$207K 0.1% 199

Other funds holding CYTK

MCP
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Veracity Capital's CYTK Position: Q3 2026 in Review

Veracity Capital increased its Cytokinetics (CYTK) stake by 0.01% in Q3 2026, buying an estimated $76 and bringing the position to 7,420 shares worth $489K. The position accounts for 0.13% of the portfolio, ranked #132.

Veracity Capital first reported a position in CYTK in Q1 2021 and has held it in 22 quarters since. The position peaked at $632K in Q2 2026. 10 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Veracity Capital held 7,420 shares of Cytokinetics worth $489K as of Q3 2026.
  • Veracity Capital bought 1 Cytokinetics share in Q3 2026, an estimated $76.
  • Cytokinetics made up 0.13% of Veracity Capital's portfolio in Q3 2026, its #132 holding.
  • Veracity Capital first reported a position in Cytokinetics in Q1 2021 and has held it in 22 quarters since.
  • Veracity Capital's Cytokinetics position peaked at $632K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.